Bioceres Crop Solutions (NASDAQ:BIOX) Given New $7.00 Price Target at Oppenheimer

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective cut by Oppenheimer from $8.00 to $7.00 in a report released on Tuesday morning,Benzinga reports. They currently have an outperform rating on the stock.

A number of other research analysts have also recently commented on the company. Lake Street Capital cut their target price on Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating on the stock in a research note on Friday, February 7th. Canaccord Genuity Group cut their price objective on Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $8.63.

Bioceres Crop Solutions Stock Performance

Shares of NASDAQ:BIOX opened at $4.28 on Tuesday. The company has a current ratio of 1.33, a quick ratio of 0.96 and a debt-to-equity ratio of 0.43. Bioceres Crop Solutions has a 12 month low of $3.51 and a 12 month high of $13.18. The company has a market capitalization of $268.40 million, a price-to-earnings ratio of 214.11 and a beta of 0.60. The firm’s 50-day moving average is $4.43 and its 200 day moving average is $5.90.

Institutional Trading of Bioceres Crop Solutions

Several institutional investors and hedge funds have recently modified their holdings of BIOX. Fourth Sail Capital LP increased its holdings in Bioceres Crop Solutions by 16.6% during the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock worth $22,490,000 after purchasing an additional 527,859 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Bioceres Crop Solutions by 135.0% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company’s stock worth $4,574,000 after buying an additional 432,206 shares in the last quarter. Long Focus Capital Management LLC increased its stake in shares of Bioceres Crop Solutions by 130.7% during the fourth quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company’s stock valued at $4,528,000 after buying an additional 421,931 shares during the period. Ballast Asset Management LP raised its holdings in shares of Bioceres Crop Solutions by 23.5% in the fourth quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock valued at $2,620,000 after acquiring an additional 82,187 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in Bioceres Crop Solutions by 49.3% in the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after acquiring an additional 29,693 shares during the period. Institutional investors own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.